Cronin-Fenton D , Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Hansen H, Fryzek J, Lawrence D, Walker J, Mellemgaard A, Rasmussen TR, Shire N, Rigas J, Potter D, Hamilton-Dutoit S, Sorensen HT. PD-L1 expression, EGFR and KRAS mutations in First-Line Therapy (1L) for non-small cell lung cancer (NSCLC) patients. Presented at the 18th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) 2017, October 15-18, 2017, Yokohama, Japan.